Status:
UNKNOWN
Simulated Amniotic Fluid Solution in Neonates Recovering From GIT Surgeries
Lead Sponsor:
Rania Ali El-Farrash
Conditions:
Necrotizing Enterocolitis
Eligibility:
All Genders
Up to 28 years
Phase:
PHASE1
Brief Summary
Amniotic fluid plays a significant role in fetal gut maturation and development. The human fetus swallows over 200 ml of amniotic fluid per kilogram of weight each day and such swallowing is essential...
Detailed Description
Neonates with congenital GIT anomalies will participate after being operated. Participants will be followed for the duration of hospital stay until discharge or death.
Eligibility Criteria
Inclusion
- Neonates with operable congenital bowel abnormalities
Exclusion
- Critically ill babies.
- Presence of any contraindications to enteral feeding
Key Trial Info
Start Date :
July 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2018
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03302338
Start Date
July 1 2015
End Date
October 1 2018
Last Update
October 5 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University
Cairo, Egypt, 1138